DBV Technologies to Participate in Upcoming AAAAI 2024 Congr

Montrouge, France, February 20 2024 DBV Technologies to Participate in Upcoming AAAAI 2024 Congress DBV Technologies , a clinical-stage biopharmaceutical company focused on treatments for food...

Related Keywords

Montrouge , France General , France , United States , Washington , Colorado , American , Julie Wang , David Fleischer , Aurora Krause , Hugh Sampson , Jean Marc Busnel Beckman Coulter , Katie Matthews , Pharis Mohideen , Exchange Commission , Company Adss , Beckman Coulter , Convention Center , Icahn School Of Medicine At Mount Sinai , Beckman Coulter Life Sciences , American Academy Of Allergy , Nasdaq , American Academy , Annual Meeting , Hospital Colorado , Label Extension , Icahn School , Mount Sinai , Viaskin Peanut , Early Intervention , Peanut Allergy , Product Theater , Medical Officer , Streamlined Approach , Basophil Activation Testing , Longitudinal Characterization , Peanut Allergy During , Multi Site Phase , Blind Placebo Controlled Trial , Jean Marc Busnel , Safety Results , Peanut Allergic Children Aged , Associate Professor , Ige Mediated Food , North American , Basking Ridge , Euronext Paris , Nasdaq Global Select Market , Des March , Markets ,